During the past decade, Toyohashi Heart Center conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Toyohashi Heart Center" #1 collaborator was "Chiltern International Inc." with 1 trials as a collaborator and "Medtronic Japan Co., Ltd." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Toyohashi Heart Center" are "Arterial Occlusive Diseases" (1 trials), "Atrial Fibrillation" (1 trials), "Cardiovascular Diseases" (1 trials), "Coronary Artery Disease" (1 trials) and "Myocardial Ischemia" (1 trials). Many other conditions were trialed in "Toyohashi Heart Center" in a lesser frequency.

Most popular intervention types in "Toyohashi Heart Center" are "Device" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Edoxaban-based Regimen" (1 trials), "MDT-4107 Drug Eluting Stent" (1 trials) and "VKA-based Regimen" (1 trials). Other intervention names were less common.

The vast majority of trials in "Toyohashi Heart Center" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Toyohashi Heart Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Toyohashi Heart Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Toyohashi Heart Center, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".